Table 4

Summary of the type and quality of evidence for mortality outcomes

    No of Studies

    Design

    Mortality outcome*

    Consistency

    Generalizability (location)

    Relative Risk (95% CI)

    Grade

    Comments


3

prospective cohort studies

All causes, among all live births

marginal heterogeneity from meta analysis (p=0.076); all studies show a benefit

South Asia, West Africa

0.56 (0.40 – 0.79)

Random effects meta analysis

3

prospective cohort studies

All causes, among low birth weight babies

Q test for heterogeneity from meta analysis (p=0.585); two of three studies show a benefit

South Asia, West Africa

0.58(0.43 – 0.78)

Random effects meta analysis

3

prospective cohort studies

Infection-related causes, among all live births

Q test for heterogeneity from meta analysis (p=0.134); one of three studies shows a benefit

South Asia, West Africa

0.55 (0.36 – 0.84)

Random effects meta analysis

3

prospective cohort studies

Sepsis-specific mortality, among all live births

Q test for heterogeneity from meta analysis (p=0.138); all studies show a benefit

South Asia, West Africa

0.42 (0.23 – 0.74)

Random effects meta analysis

3

prospective cohort studies

Birth asphyxia-specific mortality, among all live births

Q test for heterogeneity from meta analysis (p=0.887); zero of three studies show a benefit

South Asia, West Africa

0.50 (0.23 – 1.12)

Random effects meta analysis

2

prospective cohort studies

Prematurity-specific mortality, among all live births

Q test for heterogeneity from meta analysis (p=0.418); one of two studies show a benefit

South Asia, West Africa

0.56 (0.30, 1.02)

Random effects meta analysis


Debes et al. BMC Public Health 2013 13(Suppl 3):S19   doi:10.1186/1471-2458-13-S3-S19

Open Data